国家基本医保310个目录外药品通过形式审查破纪录，科创100ETF华夏（588800）开盘冲高上涨！

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index increased by 0.71%, with notable stock performances including Zhuhai Guanyu up 6.42% and BZJ Engineering up 5.88% [1] - The Huaxia Sci-Tech 100 ETF (588800) rose by 0.62%, with a recent price of 1.13 yuan, and has seen a cumulative increase of 2.55% over the past week [1] - The Huaxia Sci-Tech 100 ETF's trading volume reached 50.33 million yuan, with an average daily trading volume of 265 million yuan over the past year [1] Group 2 - The National Healthcare Security Administration announced the latest progress in the adjustment of the 2025 National Basic Medical Insurance Directory, with 534 drug names passing the preliminary review, a significant increase from 249 in 2024 [2] - The CXO industry in China is experiencing an adjustment phase due to a cooling in pharmaceutical market investments and high base effects from COVID-19 orders, with a recovery in overseas market demand expected by the end of 2023 [2] - The active Hong Kong stock market and the reopening of listing channels for unprofitable companies on the Sci-Tech Innovation Board are anticipated to further stimulate domestic demand, leading to a new development phase for the CXO industry chain [2]